CSPC Pharmaceutical Group Limited Cash Flow Quality Index
CSPC Pharmaceutical Group Limited cash flow quality index. CSPC Pharmaceutical Group Limited (CVG) has a Cash Flow Quality Index of 1.79x as of September 2020. Operating cash flow of €2.16 Billion exceeds net income of €1.20 Billion, indicating high earnings quality where cash backs reported profits. See CSPC Pharmaceutical Group Limited free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of CSPC Pharmaceutical Group Limited (2013–2025)
Cash flow quality index of CSPC Pharmaceutical Group Limited from 2013 to 2025. Historical Cash Flow Quality Index for CSPC Pharmaceutical Group Limited across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can CSPC Pharmaceutical Group Limited service its debt to assess how comfortably operating cash covers total debt obligations.
CSPC Pharmaceutical Group Limited Cash Flow Quality Index by Year (2013–2025)
CSPC Pharmaceutical Group Limited cash flow quality index by year from 2013 to 2025. Year-by-year earnings quality comparison for CSPC Pharmaceutical Group Limited. For the full cash flow conversion analysis, see CSPC Pharmaceutical Group Limited cash conversion from operations.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.50x | €5.83 Billion | €3.88 Billion | ▲ +53.4% |
| 2024 | 0.98x | €4.53 Billion | €4.63 Billion | ▲ +49.5% |
| 2023 | 0.65x | €4.18 Billion | €6.38 Billion | ▼ -40.3% |
| 2022 | 1.10x | €7.63 Billion | €6.95 Billion | ▲ +63.4% |
| 2021 | 0.67x | €4.64 Billion | €6.90 Billion | ▼ -38.6% |
| 2020 | 1.09x | €6.74 Billion | €6.16 Billion | ▲ +7.4% |
| 2019 | 1.02x | €3.78 Billion | €3.71 Billion | ▼ -17.3% |
| 2018 | 1.23x | €3.80 Billion | €3.08 Billion | ▲ +3.8% |
| 2017 | 1.19x | €3.29 Billion | €2.77 Billion | ▼ -23.4% |
| 2016 | 1.55x | €2.92 Billion | €1.88 Billion | ▲ +14.8% |
| 2015 | 1.35x | €2.25 Billion | €1.67 Billion | ▼ -5.2% |
| 2014 | 1.42x | €1.81 Billion | €1.27 Billion | ▲ +70.0% |
| 2013 | 0.84x | €814.86 Million | €972.75 Million | — |